SAMU
DMAA

SONA Asset Management (US)’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

SONA Asset Management (US)’s Portfolio DMAA Stock Details DMAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73M Hold
162,795
– – 0.04% 270
2026
Q1 		$1.71M Buy
+162,795
New +$1.7M 0.04% 217

Other funds holding DMAA

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

SONA Asset Management (US)'s DMAA Position: Q2 2026 in Review

SONA Asset Management (US) held its Drugs Made In America Acquisition Corp (DMAA) position steady in Q2 2026 at 162,795 shares worth $1.73M. The position accounts for 0.04% of the portfolio, ranked #270.

SONA Asset Management (US) first reported a position in DMAA in Q1 2026 and has held it in 2 quarters since. 23 funds tracked by Wall St. Rank hold DMAA as of Q2 2026.

  • SONA Asset Management (US) held 162,795 shares of Drugs Made In America Acquisition Corp worth $1.73M as of Q2 2026.
  • SONA Asset Management (US) left its Drugs Made In America Acquisition Corp share count unchanged in Q2 2026.
  • Drugs Made In America Acquisition Corp made up 0.04% of SONA Asset Management (US)'s portfolio in Q2 2026, its #270 holding.
  • SONA Asset Management (US) first reported a position in Drugs Made In America Acquisition Corp in Q1 2026 and has held it in 2 quarters since.
  • 23 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q2 2026.

Based on SONA Asset Management (US)'s 13F filing for Q2 2026, filed 14 Aug 2026.